A role for inflammation in the development of T2DM has been proposed for many years on account of the observed relationships between higher concentrations of biomarkers of inflammation, such as CRP and interleukin-6 (IL-6), and T2DM risk [22]. This evidence concerns the gene IL6 and type 2 diabetes mellitus.